|

Resolution
- RE nš 530, 17 April 2001*
(DO dated 06/08/01)
As the Chairman
of the Collegiate Directorate of the Brazilian Sanitary Surveillance
Agency, in the use of the attributions vested in it by Administrative
Order nº 724 of the Chairman-Chairman, dated 10 October 2000,
and considering that disposed in § 3 of article 111 of the
Internal Regulation approved by Administrative Order nº 593,
dated 25 August 2000,
WHEREAS that
disposed in article 8 and article 41 of Law nº 9.782, dated
26 January 1999;
WHEREAS that disposed in articles 6 and 7 of Law nº 6.360
dated 23 September 1976;
WHEREAS medicines based on the substance CISAPRIDE are associated
to the development of serious adverse reactions;
WHEREAS the need to monitor adverse reactions during treatment
with these medicines;
WHEREAS some companies that possess a license for CISAPRIDE-based
medicines do not develop actions of pharmacovigilance that allow
for the monitoring of prescriptions and adverse reactions of these
medicines, I hereby resolve to:
Art.1 Cancel the licenses of CISAPRIDE-based medicines according
to the annexed list.
Art. 2 Grant a period of 30 (thirty) days counting from the publication
date of this Resolution for the companies that possess a license
of the medicines dealt with in Article 1 to withdraw their medicines
from the national territory.
Art. 3 Inform the companies that possess a license of the cancelled
medicines that:
a) they
can maintain their trademarks as long as they present a formula
alteration petition to ANVISA substituting the CISAPRIDE of
the original formula and that the words “NEW FORMULA”
are highlighted in the instructions for use and label.
b) If they can prove the existence of pharmacovigilance actions
they can request a new license of the product.
Art. 4 The manipulation of magistral formulas containing CISAPRIDE
is forbidden.
Sole Paragraph. The Local Sanitation Authority must adopt the
appropriate measures regarding the existent stocks in the establishments
under their jurisdiction.
Art. 6 Failure to comply with the provisions contained in this
Resolution shall constitute sanitary infraction, subjecting the
offenders to the penalties provided for in the legislation in
force.
Art. 7 This Resolution shall enter into force on the date of its
publication.
GONZALO VECINA NETO
ANNEX
List
of Medicines
| Name |
License
N.º/ Ministry of Health |
Manufacturer |
| Kineprid®
|
1.0646.0134
|
Laboratório
Químico Farmacêutico Bergamo Ltda. |
| Normotil®
|
1.1013.0014
|
Laboratórios
Klinger do Brasil Ltda. |
| Cisatec®
|
1.0573.0244 |
Aché
Laboratórios Farmaceuticos S.A. |
| Cispride®
|
1.0082.0108
|
Laboratórios
Sintofarma S.A... |
| Cisapan®
|
1.0550.0075 |
UCI
Farma Industria Farmacêutica Ltda. |
| Cinetic®
|
1.0974.0072
|
Biolab
Sanus Farmacêutica Ltda. |
| Cimetic® |
1.0974.0012 |
Biolab
Sanus Farmacêutica Ltda. |
(*)
Republished due to errors in the original published in the Official
Gazette of the Union nº 75-E, section 1, page 147, dated
18 April 2001.
|